ferric carboxymaltose IV iron
Selected indexed studies
- IV iron formulations and use in adults. (Hematology Am Soc Hematol Educ Program, 2023) [PMID:38066930]
- Ferric Carboxymaltose (FCM)-Associated Hypophosphatemia (HPP): A Systematic Review. (Am J Hematol, 2025) [PMID:39935027]
- Clinical effectiveness of ferric carboxymaltose (iv) versus iron sucrose (iv) in treatment of iron deficiency anaemia in pregnancy: A systematic review and meta-analysis. (Indian J Med Res, 2024) [PMID:38439125]
_Worker-drafted node — pending editorial review._
Connections
ferric carboxymaltose IV iron is a side effect of
Sources
- IV iron formulations and use in adults. (2023) pubmed
- Ferric Carboxymaltose (FCM)-Associated Hypophosphatemia (HPP): A Systematic Review. (2025) pubmed
- Clinical effectiveness of ferric carboxymaltose (iv) versus iron sucrose (iv) in treatment of iron deficiency anaemia in pregnancy: A systematic review and meta-analysis. (2024) pubmed
- Safety and Efficacy of Ferric Carboxymaltose for Iron Deficiency Anemia in Inflammatory Bowel Disease: A Systematic Review. (2024) pubmed
- Oral and Intravenous Iron Therapy. (2025) pubmed
- Single-dose intravenous iron vs oral iron for treatment of maternal iron deficiency anemia: a randomized clinical trial. (2025) pubmed
- Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline. (2025) pubmed
- Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure (FAIR-HF2-DZHK05) trial: Baseline characteristics and comparison to other relevant clinical trials. (2025) pubmed
- Intravenous ferric carboxymaltose and ferric derisomaltose alter the intestinal microbiome in female iron-deficient anemic mice. (2023) pubmed
- Ferric carboxymaltose for iron deficiency in patients with heart failure: a systematic review and meta-analysis. (2024) pubmed